Latest news
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome - GlobeNewswireGlobeNewswire · Mon, 03 Aug 2026 11:00:00 GMTCan-Fite launches Phase 2 trial of Piclidenoson for rare genetic Lowe syndrome, targeting kidney disease. - PluangPluang · Mon, 03 Aug 2026 07:00:00 GMT